Medication info

Raniton 150 mg (Ranitidine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
HLB Pharma Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201901832 · Approved 2019.03.27

This product's status changed to Expired on 2024.03.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions and bleeding, and prevention of Mendelson syndrome
Who takes it
Adults · Children
Adult dose
1. Adults Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this drug orally twice daily or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage regimen is the same when this drug is used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, or within 8 weeks for disease caused by nonsteroidal anti-inflammatory drugs, although healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this drug twice daily for 8 weeks or 300 mg once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg four times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 150 mg of this drug three times daily, and increase the dose as necessary. For severe disease, up to 6 g per day may be administered as directed by a physician. 4) For upper gastrointestinal bleeding caused by peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral treatment with 150 mg of this drug twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 150 mg of this drug 2 hours before induction of anesthesia. It is also preferable to administer 150 mg on the evening before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this drug once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.
Child dose
For ages 8 〜 18, 150 mg per dose (2 mg per kg of body weight), up to twice daily

Ingredients

Manufacturer
HLB Pharma Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions and bleeding, and prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-operative ulcers
  • NSAID-induced gastric and duodenal ulcers
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • edema
  • acute gastritis
View approved original text

This medication is used to treat gastrointestinal disorders such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. Additionally, it is effective in preventing ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs) and in pre-operative administration for the prevention of Mendelson's syndrome. It also helps improve damage to the gastric mucosa associated with acute gastritis or exacerbations of chronic gastritis, as well as upper gastrointestinal bleeding (erosion, hemorrhage, redness, edema). In summary, it is used to prevent damage to the gastric mucosa and assist in healing to improve gastric health.

How to take

Adult dose

1. Adults Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this drug orally twice daily or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage regimen is the same when this drug is used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, or within 8 weeks for disease caused by nonsteroidal anti-inflammatory drugs, although healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this drug twice daily for 8 weeks or 300 mg once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg four times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 150 mg of this drug three times daily, and increase the dose as necessary. For severe disease, up to 6 g per day may be administered as directed by a physician. 4) For upper gastrointestinal bleeding caused by peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral treatment with 150 mg of this drug twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 150 mg of this drug 2 hours before induction of anesthesia. It is also preferable to administer 150 mg on the evening before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this drug once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.

Child dose

For ages 8 〜 18, 150 mg per dose (2 mg per kg of body weight), up to twice daily

Precautions

This medication should not be used in patients who have had an allergic reaction to its components. Patients with a history of acute porphyria should avoid this medication as it may worsen symptoms. It contains lactose, so patients with lactose intolerance or certain genetic metabolic disorders should not be administered this drug. Patients with impaired renal function may require dosage adjustments or an alteration of dosing intervals due to potential drug accumulation. Patients with decreased liver function should also use caution. Patients who have previously experienced drug allergic reactions should take this medication cautiously. Elderly patients should be careful as drug responses may vary due to declining physical function. When taken with non-steroidal anti-inflammatory drugs, the risk of gastrointestinal bleeding requires regular monitoring. This medication may mask symptoms of gastric cancer, so patients with gastric ulcers or middle-aged patients with newly developed dyspepsia should verify malignancy before taking it. Patients with Helicobacter pylori infection have a gastric or duodenal ulcer that must be treated with eradication therapy. This medication can rarely cause serious allergic reactions such as anaphylactic shock, so if any abnormal symptoms occur while taking it, stop immediately and inform healthcare personnel. Be aware of possible hypersensitivity reactions such as hives, rash, difficulty breathing, and low blood pressure. Blood tests may show leukopenia, thrombocytopenia, or other blood abnormalities, so if there are symptoms of fatigue, bleeding, or fever, testing is needed. Signs of liver dysfunction may occur, so treatment should be sought immediately if symptoms such as jaundice or fatigue appear. Rarely reported cardiovascular reactions include arrhythmias and vasculitis. Gastrointestinal symptoms like constipation, nausea, and abdominal pain may arise, and if discomfort persists, consultation is advisable. Dizziness, drowsiness, headache, and confusion may occur, so it's best to avoid driving or operating hazardous machinery. Endocrine side effects such as gynecomastia or erectile dysfunction have been reported occasionally. Myalgia or arthralgia may appear, and if persistent, should be discussed with a physician. Skin rashes or hair loss have been reported rarely, so report any abnormal signs. During treatment, observe the condition of the disease closely and use the minimum required dose; if there is no effect, consider alternative therapies. Elderly individuals, those with chronic lung disease, and diabetic patients are at higher risk for pneumonia and should be cautious. If dizziness or drowsiness occurs, refrain from driving or operating machinery. Drug interactions may occur, so inform your healthcare provider of any medications you are currently taking, especially anticoagulants, as blood tests should monitor your condition if used together. Certain medications may affect absorption or excretion, requiring adjustments in administration intervals. Women who are pregnant or may become pregnant should use this medication cautiously, and nursing mothers should only take it if necessary, as it can pass into breast milk. Safety in children has not been fully established, so caution is warranted. Elderly patients are often at risk for decreased renal function, requiring careful dosing adjustments or prolongation of intervals. This medication may influence the results of certain clinical tests, so discuss the testing methods with healthcare personnel. In case of overdose, specific symptoms are rare, but symptomatic treatment such as vomiting or gastric lavage may be necessary. Store out of reach of children, and do not transfer to another container as a safety measure.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine level
Show 57 more
  • leukopenia
  • thrombocytopenia
  • bone marrow suppression
  • aplastic anemia
  • hypoplastic anemia
  • agranulocytosis
  • pancytopenia
  • acquired immune hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous and mucosal bleeding
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • heart block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • convulsions
  • headache
  • heaviness
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurry vision
  • involuntary movement disorder
  • altered consciousness
  • hepatomegaly
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • stomatitis
  • pruritus
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in containers that block light. Additionally, it is essential to maintain a room temperature of 1°C to 30°C when storing the medication to safely preserve its efficacy.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.